img

Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Industry Outlook 2024: Overview, Opportunities, Key Companies and Forecast to 2034


Published on: 2024-01-04 | No of Pages : 320 | Industry : Medical Devices & Consumables

Publisher : GRD Survey | Format : PDF

Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Industry Outlook 2024: Overview, Opportunities, Key Companies and Forecast to 2034

Executive Summary

According to GRD Survey data, the global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers market is estimated at 4510 million US$ in 2021 and is expected to reach 7840 million US$ by the end of 2028, growing at a CAGR of 8.2% in the forecast period between 2022 and 2028.

This report studies the Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (value and volume) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)

Market Snapshot, By Product Type
Hemostats
Internal Tissue Sealants
Adhesion Barriers

Market Snapshot, By Application
Hospitals
Clinics & Trauma Centers
Ambulatory Surgical Centers

Main Market Players Analyzed in this report, including
Tissuemed
Sanofi
Pfizer
Integra Lifesciences
Ethicon
Cryolife
Cohera Medical
C. R. Bard
Baxter
B. Braun Melsungen

The study objectives of this report are
To study and analyze the global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers market size (value & volume) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers are as follows
History Year2016-2020
Base Year2020
Estimated Year2021
Forecast Year 2021 to 2027

This report includes the estimation of market size in terms of value (million USD) and volume from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.

For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders Considered in the study
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries

Table of Content

Table of Contents

1 Market Definition & Scope
1.1 Definition & Scope
1.2 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Performance and Outlook

2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter’s Five Forces Analysis
2.3 Comparison of Alternatives and Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers

3 Supply Chain and Manufacturing Cost Analysis
3.1 Supply Chain Analysis
3.2 Raw Materials and Key Suppliers Analysis
3.2.1 Raw Materials Introduction
3.2.1 Raw Materials Key Suppliers List
3.3 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales Channel and Distributors Analysis
3.3.1 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales Channel
3.3.2 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Distributors
3.4 Key Buying Industries/Consumers
3.4.1 Major Buyers in Hospitals
3.4.2 Major Buyers in Clinics & Trauma Centers
3.5 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Manufacturing Cost Structure Analysis

4 Market Segment: by Type
4.1 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Type Introduction
4.1.1 Hemostats
4.1.2 Internal Tissue Sealants
4.1.3 Adhesion Barriers
4.2 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales by Type 2016-2021
4.3 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue by Type 2016-2021
4.4 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Price by Type 2016-2021

5 Market Segment: by Application
5.1 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Type Introduction
5.1.1 Hospitals
5.1.2 Clinics & Trauma Centers
5.1.3 Ambulatory Surgical Centers
5.2 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales by Application 2016-2021
5.3 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue by Application 2016-2021
5.4 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Price by Application 2016-2021

6 Marke Segment: by Region
6.1 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market by Region
6.1.1 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales by Regions
6.1.2 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue by Regions
6.2 North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market 2016-2021
6.3 Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market 2016-2021
6.4 Asia Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market 2016-2021
6.5 South America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market 2016-2021
6.6 Middle East and Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market 2016-2021

7 North America
7.1 North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market by Country 2016-2021
7.1.1 North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales by Country
7.1.2 North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue by Country
7.2 United States
7.3 Canada
7.4 Mexico

8 Europe
8.1 Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market by Country 2016-2021
8.1.1 Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales by Country
8.1.2 Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue by Country
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain

9 Asia Pacific
9.1 Asia Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market by Country 2016-2021
9.1.1 Asia Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales by Country
9.1.2 Asia Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue by Country
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia

10 South America
10.1 South America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market by Country 2016-2021
10.1.1 South America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales by Country
10.1.2 South America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue by Country
10.2 Brazil
10.3 Argentina
10.4 Colombia

11 Middle East and Africa
11.1 Middle East and Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market by Country 2016-2021
11.1.1 Middle East and Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales by Country
11.1.2 Middle East and Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue by Country
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa

12 Key Participants Company Information
12.1 Tissuemed
12.1.1 Tissuemed Company Information
12.1.2 Tissuemed Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product Portfolio, Specification and Application
12.1.3 Tissuemed Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales, Price, Revenue and Gross Margin (2019-2021)
12.1.4 Tissuemed Key Development
12.2 Sanofi
12.2.1 Sanofi Company Information
12.2.2 Sanofi Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product Portfolio, Specification and Application
12.2.3 Sanofi Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales, Price, Revenue and Gross Margin (2019-2021)
12.2.4 Sanofi Key Development
12.3 Pfizer
12.3.1 Pfizer Company Information
12.3.2 Pfizer Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product Portfolio, Specification and Application
12.3.3 Pfizer Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales, Price, Revenue and Gross Margin (2019-2021)
12.3.4 Pfizer Key Development
12.4 Integra Lifesciences
12.4.1 Integra Lifesciences Company Information
12.4.2 Integra Lifesciences Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product Portfolio, Specification and Application
12.4.3 Integra Lifesciences Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales, Price, Revenue and Gross Margin (2019-2021)
12.4.4 Integra Lifesciences Key Development
12.5 Ethicon
12.5.1 Ethicon Company Information
12.5.2 Ethicon Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product Portfolio, Specification and Application
12.5.3 Ethicon Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales, Price, Revenue and Gross Margin (2019-2021)
12.5.4 Ethicon Key Development
12.6 Cryolife
12.6.1 Cryolife Company Information
12.6.2 Cryolife Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product Portfolio, Specification and Application
12.6.3 Cryolife Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales, Price, Revenue and Gross Margin (2019-2021)
12.6.4 Cryolife Key Development
12.7 Cohera Medical
12.7.1 Cohera Medical Company Information
12.7.2 Cohera Medical Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product Portfolio, Specification and Application
12.7.3 Cohera Medical Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales, Price, Revenue and Gross Margin (2019-2021)
12.7.4 Cryolife Key Development
12.9 Baxter
12.9.1 Baxter Company Information
12.9.2 Baxter Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product Portfolio, Specification and Application
12.9.3 Baxter Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales, Price, Revenue and Gross Margin (2019-2021)
12.9.4 Baxter Key Development
12.8 C. R. Bard
12.8.1 C. R. Bard Company Information
12.8.2 C. R. Bard Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product Portfolio, Specification and Application
12.8.3 C. R. Bard Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales, Price, Revenue and Gross Margin (2019-2021)
12.8.4 C. R. Bard Key Development

13 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Forecast by Region by Type and by Application
13.1 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales, Revenue Forecast 2022-2027
13.2 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Forecast by Regions
13.2.1 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales Forecast by Region 2022-2027
13.2.2 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Forecast by Region 2022-2027
13.3 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Forecast by Type
13.3.1 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales Forecast by Type 2022-2027
13.3.2 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Forecast by Type 2022-2027
13.3.3 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Price Forecast by Type 2022-2027
13.4 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Forecast by Application
13.4.1 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales Forecast by Application 2022-2027
13.4.2 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Forecast by Application 2022-2027
13.4.3 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Price Forecast by Application 2022-2027

14 Analyst Views and Conclusions

15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer

List of Figure

List of Tables

Table 1: Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production Specifications
Table 2: Drivers in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market
Table 3: Restraints Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market
Table 4: Opportunity in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market
Table 5: Comparion of Alternative and Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers
Table 6: Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Raw Materials Key Suppliers List
Table 7: Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Distributors List
Table 8: Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Major Buyers in Hospitals
Table 9: Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Major Buyers in Clinics & Trauma Centers
Table 10: Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Major Buyers in Ambulatory Surgical Centers
Table 11: Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales (K Units) by Type 2016-2021
Table 12: Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales Market Share by Type 2016-2021
Table 13: Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (Million USD) by Type 2016-2021
Table 14: Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Share by Type 2016-2021
Table 15: Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Price by Type 2016-2021
Table 16: Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales (K Units) by Application 2016-2021
Table 17: Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales Market Share by Application 2016-2021
Table 18: Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (Million USD) by Application 2016-2021
Table 19: Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Share by Application 2016-2021
Table 20: Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Price by Application 2016-2021
Table 21: Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales (K Units) by Region 2016-2021
Table 22: Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales Market Share by Region 2016-2021
Table 23: Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (Million USD) by Region 2016-2021
Table 24: Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Share by Region 2016-2021
Table 25: North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales (K Units) by Country 2016-2021
Table 26: North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales Market Share by Country 2016-2021
Table 27: North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (Million USD) by Country 2016-2021
Table 28: North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Share by Country 2016-2021)
Table 29: Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales (K Units) by Country 2016-2021
Table 30: Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales Market Share by Country 2016-2021
Table 31: Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (Million USD) by Country 2016-2021
Table 32: Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Share by Country 2016-2021)
Table 33: Asia Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales (K Units) by Country 2016-2021
Table 34: Asia Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales Market Share by Country 2016-2021
Table 35: Asia Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (Million USD) by Country 2016-2021
Table 36: Asia Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Share by Country 2016-2021)
Table 37: South America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales (K Units) by Country 2016-2021
Table 38: South America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales Market Share by Country 2016-2021
Table 39: South America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (Million USD) by Country 2016-2021
Table 40: South America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Share by Country 2016-2021)
Table 41: Middle East and Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales (K Units) by Country 2016-2021
Table 42: Middle East and Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales Market Share by Country 2016-2021
Table 43: Middle East and Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (Million USD) by Country 2016-2021
Table 44: Middle East and Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Share by Country 2016-2021)
Table 45 Tissuemed Company Information
Table 46 Tissuemed Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product Portfolio, Specification and Application
Table 47 Tissuemed Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales, Price, Revenue and Gross Margin (2019-2021)
Table 48 Sanofi Company Information
Table 49 Sanofi Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product Portfolio, Specification and Application
Table 50 Sanofi Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales, Price, Revenue and Gross Margin (2019-2021)
Table 51 Pfizer Company Information
Table 52 Pfizer Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product Portfolio, Specification and Application
Table 53 Pfizer Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales, Price, Revenue and Gross Margin (2019-2021)
Table 54 Integra Lifesciences Company Information
Table 55 Integra Lifesciences Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product Portfolio, Specification and Application
Table 56 Integra Lifesciences Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales, Price, Revenue and Gross Margin (2019-2021)
Table 57 Ethicon Company Information
Table 58 Ethicon Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product Portfolio, Specification and Application
Table 59 Ethicon Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales, Price, Revenue and Gross Margin (2019-2021)
Table 60 Cryolife Company Information
Table 61 Cryolife Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product Portfolio, Specification and Application
Table 62 Cryolife Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales, Price, Revenue and Gross Margin (2019-2021)
Table 63 Cohera Medical Company Information
Table 64 Cohera Medical Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product Portfolio, Specification and Application
Table 65 Cohera Medical Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales, Price, Revenue and Gross Margin (2019-2021)
Table 66 C. R. Bard Company Information
Table 67 C. R. Bard Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product Portfolio, Specification and Application
Table 68 C. R. Bard Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales, Price, Revenue and Gross Margin (2019-2021)
Table 69 Baxter Company Information
Table 70 Baxter Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product Portfolio, Specification and Application
Table 71 Baxter Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales, Price, Revenue and Gross Margin (2019-2021)
Table 72: Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales (K Units) Forecast by Region (2022-2027)
Table 73: Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales Market Share Forecast by Region (2012-2027)
Table 74: Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (Million USD) Forecast by Region (2022-2027)
Table 75: Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Share Forecast by Region (2022-2027)
Table 76: Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales (K Units) Forecast by Type (2022-2027)
Table 77: Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales Market Share Forecast by Type (2012-2027)
Table 78: Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (Million USD) Forecast by Type (2022-2027)
Table 79: Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Share Forecast by Type (2022-2027)
Table 80: Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales (K Units) Forecast by Applicaion (2022-2027)
Table 81: Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales Market Share Forecast by Application (2012-2027)
Table 82: Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (Million USD) Forecast by Application (2022-2027)
Table 83: Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Share Forecast by Application (2022-2027)


List of Figures

Figure 1: Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Picture
Figure 2: Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size (Million USD) and Growth Rate (2016-2027)
Figure 3: Porter's Five Forces Analysis
Figure 4: Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Supply Chain Analysis
Figure 5: Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Manufacturing Cost Structure Analysis
Figure 6: Product Picture of Hemostats
Figure 7: Product Picture of Internal Tissue Sealants
Figure 8: Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales Market Share by Type, 2020
Figure 9: Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Share by Type, 2020
Figure 10: Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers in Hospitals
Figure 11: Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market: Hospitals 2016-2021
Figure 12: Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers in Clinics & Trauma Centers
Figure 13: Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market: Clinics & Trauma Centers 2016-2021
Figure 14: Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales Market Share by Application, 2020
Figure 15: Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Share by Application, 2020
Figure 16: Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales Market Share by Region 2016-2021
Figure 17: Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Share by Region 2016-2021
Figure 18: North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales (K Units) Status 2016-2021
Figure 19: North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (Million USD) Status 2016-2021
Figure 20: Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales (K Units) Status 2016-2021
Figure 21: Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (Million USD) Status 2016-2021
Figure 22: Asia Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales (K Units) Status 2016-2021
Figure 23: Asia Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (Million USD) Status 2016-2021
Figure 24: South America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales (K Units) Status 2016-2021
Figure 25: South America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (Million USD) Status 2016-2021
Figure 26: Middle East and Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales (K Units) Status 2016-2021
Figure 27: Middle East and Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (Million USD) Status 2016-2021
Figure 28: North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales Market Share by Country, 2020
Figure 29: North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Share by Country, 2020
Figure 30: United States Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales (K Units) Status 2016-2021
Figure 31: United States Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (Million USD) Status 2016-2021
Figure 32: Canada Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales (K Units) Status 2016-2021
Figure 33: Canada Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (Million USD) Status 2016-2021
Figure 34: Mexico Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales (K Units) Status 2016-2021
Figure 35: Mexico Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (Million USD) Status 2016-2021
Figure 36: Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales Market Share by Country, 2020
Figure 37: Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Share by Country, 2020
Figure 38: Germany Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales (K Units) Status 2016-2021
Figure 39: Germany Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (Million USD) Status 2016-2021
Figure 40: France Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales (K Units) Status 2016-2021
Figure 41: France Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (Million USD) Status 2016-2021
Figure 42: UK Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales (K Units) Status 2016-2021
Figure 43: UK Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (Million USD) Status 2016-2021
Figure 44: Italy Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales (K Units) Status 2016-2021
Figure 45: Italy Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (Million USD) Status 2016-2021
Figure 46: Russia Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales (K Units) Status 2016-2021
Figure 46: Russia Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (Million USD) Status 2016-2021
Figure 47: Spain Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales (K Units) Status 2016-2021
Figure 48: Spain Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (Million USD) Status 2016-2021
Figure 49: Asia Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales Market Share by Country, 2020
Figure 50: Asia Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Share by Country, 2020
Figure 51: China Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales (K Units) Status 2016-2021
Figure 52: China Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (Million USD) Status 2016-2021
Figure 53: Japan Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales (K Units) Status 2016-2021
Figure 54: Japan Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (Million USD) Status 2016-2021
Figure 55: Korea Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales (K Units) Status 2016-2021
Figure 56: Korea Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (Million USD) Status 2016-2021
Figure 57: Southeast Asia Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales (K Units) Status 2016-2021
Figure 58: Southeast Asia Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (Million USD) Status 2016-2021
Figure 59: India Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales (K Units) Status 2016-2021
Figure 60: India Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (Million USD) Status 2016-2021
Figure 61: Australia Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales (K Units) Status 2016-2021
Figure 62: Australia Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (Million USD) Status 2016-2021
Figure 63: South America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales Market Share by Country, 2020
Figure 64: South America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Share by Country, 2020
Figure 65: Brazil Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales (K Units) Status 2016-2021
Figure 66: Brazil Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (Million USD) Status 2016-2021
Figure 67: Argentina Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales (K Units) Status 2016-2021
Figure 68: Argentina Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (Million USD) Status 2016-2021
Figure 69: Colombia Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales (K Units) Status 2016-2021
Figure 70: Colombia Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (Million USD) Status 2016-2021
Figure 71: Middle East and Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales Market Share by Country, 2020
Figure 72: Middle East and Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Share by Country, 2020
Figure 73: Turkey Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales (K Units) Status 2016-2021
Figure 74: Turkey Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (Million USD) Status 2016-2021
Figure 75: Saudi Arabia Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales (K Units) Status 2016-2021
Figure 76: Saudi Arabia Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (Million USD) Status 2016-2021
Figure 77: South Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales (K Units) Status 2016-2021
Figure 78: South Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (Million USD) Status 2016-2021
Figure 79: Tissuemed Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Share Globally (2019-2021)
Figure 80: Sanofi Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Share Globally (2019-2021)
Figure 81: Pfizer Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Share Globally (2019-2021)
Figure 82: Integra Lifesciences Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Share Globally (2019-2021)
Figure 83: Ethicon Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Share Globally (2019-2021)
Figure 84: Cryolife Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Share Globally (2019-2021)
Figure 85: Cohera Medical Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Share Globally (2019-2021)
Figure 86: C. R. Bard Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Share Globally (2019-2021)
Figure 87: Baxter Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Share Globally (2019-2021)
Figure 88: B. Braun Melsungen Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Market Share Globally (2019-2021)
Figure 89: Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales (K Units) Forecast (2022-2027)
Figure 90: Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales (K Units) Forecast (2022-2027)